Abbott Laboratories News

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil	Trading-Depot	Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Orderbuch			Analysen
Historisch

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Trading-Depot

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Orderbuch

Analysen

Historisch

01.08.13	FDA Approvals, Dividends, New Technologies, and Solid Margins Increase Shareholder Value - Research Report on Abbott, Baxter, CareFusion, Haemonetics, and CR Bard (PR Newswire)
30.07.13	New Data for Abbott's Investigational High Sensitive Troponin Test Shows It May Help Doctors Predict Heart Attack Risk (PR Newswire)
30.07.13	Absolute Software Launches Endpoint Monitoring and Management Solution for Managed Service Providers (PR Newswire)
29.07.13	Abbott Features Solutions to Help Labs Prepare for the Evolving Healthcare Landscape at the American Association for Clinical Chemistry Lab Expo (PR Newswire)
25.07.13	Abbott Labs Receives FDA Clearance For Advanced Blood Glucose Monitoring System (RTTNews)
25.07.13	Abbott Receives FDA Clearance for FreeStyle Precision Pro Blood Glucose and Beta-Ketone Monitoring System™ (PR Newswire)
22.07.13	Successful Integrations, Growth Brands, and Pipeline Innovations Boost Revenue Growth - Research Report on Johnson & Johnson, Abbott, St. Jude Medical, Lilly, and Novartis (PR Newswire)
17.07.13	Abbott Q2 Adj. Profit Beats View, Reiterates Full-year Outlook (RTTNews)
17.07.13	Abbott Q2 Profit Beats Estimates; Confirms FY13 EPS Guidance (RTTNews)
17.07.13	Earnings Watch For July 17(BAC, EBAY, IBM, INTC, AXP) (RTTNews)
15.07.13	Abbott To Acquire IDEV Tech., OptiMedica Corp. - Update (RTTNews)
15.07.13	Abbott Labs To Acquire IDEV Technologies, OptiMedica - Quick Facts (RTTNews)
10.07.13	Abbott Xience Xpedition Drug Eluting Stent Gets Approval In Japan (RTTNews)
10.07.13	Abbott's Next-Gen XIENCE Xpedition Stent Gets Approval In Japan - Quick Facts (RTTNews)
03.07.13	Reports: Nestle, Danone To Cut Infant Milk Prices In China Amid Probe (RTTNews)
20.02.09	Advanced Medical Optics Announces Fourth-Quarter and Full-Year 2008 Results (Businesswire)
10.02.09	Advanced Medical Optics, Inc. Announces Increase in Total Consideration and Extension of Consent Deadline in Tender Offer and Consent Solicitation for Its 7½% Senior Subordinated Notes Due 2017 (Businesswire)
16.01.09	Advanced Medical Optics Receives FDA Approval for TECNIS® Multifocal Intraocular Lens (Businesswire)
31.10.08	Advanced Medical Optics Announces Third-Quarter 2008 Results (Businesswire)
16.06.08	Advanced Medical Optics Announces Partnership with Institute for Eye Research to Develop Contact Lens Disinfectant and Cleaning Solutions (Businesswire)
10.06.08	Advanced Medical Optics Presents to the U.S. Food and Drug Administration's Ophthalmic Devices Panel of the Medical Devices Advisory Committee (Businesswire)
21.05.08	Abbott stellt Langzeitergebnisse einer Erweiterungsstudie vor, die zeigen dass die Remission bei erwachsenen, mit HUMIRA(R) (Adalimumab) behandelten Morbus-Crohn-Patienten anhält (PR Newswire)
19.05.08	ZonePerfect Dark Chocolate Nutrition Bars Indulge Chocoholics (PR Newswire)
16.05.08	Abbott Launches Next-Generation StarClose(R) SE Vascular Closure System (PR Newswire)
22.04.08	Smiths Medical to Promote and Distribute Abbott's FreeStyle Navigator Continuous Glucose Monitoring System (PR Newswire)
14.04.08	Seven Summits Research Releases Comments on IBM, ABT, CAT, DD and TXT (PR Newswire)
01.04.08	Advanced Medical Optics Introduces TECNIS(R) 1-Piece Intraocular Lens in U.S. (Businesswire)
11.03.08	Abbott Receives CE Mark for Smaller-Size XIENCE(TM) V Drug Eluting Stent (PR Newswire)
18.01.08	Abbott's HUMIRA(R) (adalimumab) Receives FDA Approval For Moderate to Severe Chronic Plaque Psoriasis (PR Newswire)
18.01.08	Abbott's HUMIRA(R) (adalimumab) Receives FDA Approval For Moderate to Severe Chronic Plaque Psoriasis (PR Newswire)
18.01.08	Abbott Announces Approval of First Fully Automated Blood Screening Test for HTLV-I/HTLV-II (PR Newswire)
04.12.07	Abbott Sets Aggressive Goal to Reduce Greenhouse Gas Emissions (PR Newswire)
30.11.07	The Magic Johnson Foundation and Abbott Expand Focus of 'Campaign to End Black AIDS' to African-American Women in 2008 (PR Newswire)
12.11.07	Abbott Receives U.S. Food and Drug Administration Approval for New Lower-Strength Kaletra(R) (lopinavir/ritonavir) Tablet for Pediatric HIV Patients (PR Newswire)
05.11.07	Abbott Confirms FDA Advisory Panel to Review XIENCE(TM) V Drug Eluting Stent on November 29 (PR Newswire)
02.11.07	Advanced Medical Optics to Present at Two Investor Conferences in November 2007 (Businesswire)
01.11.07	Abbott Researchers Target Neuronal Nicotinic Receptors for Treatment of Pain and Cognition (PR Newswire)
25.10.07	Advanced Medical Optics Announces Third-Quarter 2007 Results (Businesswire)
02.10.07	National Laboratory Associations Come Together in Support of 'Labs Are Vital' Initiative (PR Newswire)
27.09.07	Abbott's HUMIRA(R) (adalimumab) Honored With Prestigious Galen Prize for Innovation in Patient Care (PR Newswire)
27.09.07	Abbott's HUMIRA(R) (adalimumab) Honored With Prestigious Galen Prize for Innovation in Patient Care (PR Newswire)
03.08.07	Abbott Chief Operating Officer Richard A. Gonzalez to Retire (PR Newswire)
31.07.07	The Princeton Review Names Abbott One of the 'Best Companies for Entry-Level Jobs' (PR Newswire)
19.07.07	Abbott Enrolls First Patient in World's First Clinical Trial Designed to Study Drug Eluting Stent Treatment in Women (PR Newswire)
18.07.07	Advanced Medical Optics Receives FDA Approval for Advanced CustomVue(TM) Monovision Procedure for the Treatment of Presbyopic Myopes (Businesswire)
29.06.07	Neue im Journal of Pediatrics veröffentlichte Studie legt nahe, dass Synagis(R) (Palivizumab) das Folgeauftreten wiederkehrender Atembeschwerden bei Frühgeborenen verringert (PR Newswire)
18.06.07	Nearly One-Third of Chicagoans Know Little or Nothing About Diabetes, Survey Says (PR Newswire)
15.06.07	Drei Studien legen nah, dass Abbotts HUMIRA(R) (Adalimumab) möglicherweise die arbeitsbezogene Leistungsfähigkeit von Patienten mit rheumatoider Arthritis verbessert (PR Newswire)
15.06.07	Three Studies Suggest Abbott's HUMIRA(R) (adalimumab) May Improve Work Productivity in Patients with Rheumatoid Arthritis (PR Newswire)
07.06.07	Abbott's HUMIRA(R) (Adalimumab) Approved in the European Union for the Treatment of Crohn's Disease (PR Newswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Swiss Life Hldg	803.00	-0.54 %	K V
Swisscom	509.50	-0.68 %	K V
Novartis	97.84	-0.79 %	K V
Givaudan	3’798.00	-0.91 %	K V
Nestle	89.34	-1.00 %	K V
CieFinRichemont	152.95	-3.44 %	K V
Part Grp Hldg	1’246.00	-3.52 %	K V
ABB	45.22	-3.71 %	K V
UBS Group	26.87	-3.83 %	K V
Logitech Intl	73.92	-4.42 %	K V

mehr

31.03.25		Was Analysten von der Fresenius Medical Care (FMC) St-Aktie erwarten
31.03.25		So schätzen die Analysten die Zukunft der Sanofi-Aktie ein
31.03.25		März 2025: Die Expertenmeinungen zur Merck-Aktie
31.03.25		Analysten sehen bei Bayer-Aktie Potenzial
31.03.25		Was Analysten von der Fresenius SE-Aktie erwarten
31.03.25		Schwacher Wochentag in Zürich: SMI zeigt sich zum Handelsende leichter
31.03.25		Zurückhaltung in Zürich: SPI verbucht zum Ende des Montagshandels Verluste

31.03.25

Was Analysten von der Fresenius Medical Care (FMC) St-Aktie erwarten

31.03.25

So schätzen die Analysten die Zukunft der Sanofi-Aktie ein

31.03.25

März 2025: Die Expertenmeinungen zur Merck-Aktie

31.03.25

Analysten sehen bei Bayer-Aktie Potenzial

31.03.25

Was Analysten von der Fresenius SE-Aktie erwarten

31.03.25

Schwacher Wochentag in Zürich: SMI zeigt sich zum Handelsende leichter